VERA (STOCKS)
Vera Therapeutics, Inc. Class A Common Stock
$42.960000
-1.090000 (-2.47%)
Prev close: $44.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Marshall W. Fordyce
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,047.39M
- Employees
- 224
- P/E (TTM)
- -10.77
- P/B (TTM)
- 6.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.26 | $-1.16 | -0.1015 | -8.76% |
|
Jun 2025 (Q2)
|
$-1.20 | $-0.84 | -0.3619 | -43.18% |
|
Mar 2025 (Q1)
|
$-0.81 | $-0.75 | -0.0603 | -8.04% |
|
Dec 2024 (Q4)
|
$-0.72 | $-0.85 | +0.1337 | +15.66% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $18.24M |
| Operating Expenses | $270.18M |
| Research and Development | $189.29M |
| Other Operating Expenses | $80.89M |
| Operating Income/Loss | -$270.18M |
| Income/Loss From Continuing Operations After Tax | -$251.94M |
| Income/Loss From Continuing Operations Before Tax | -$251.94M |
| Net Income/Loss | -$251.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$251.94M |
| Net Income/Loss Available To Common Stockholders, Basic | -$251.94M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.99 |
| Diluted Earnings Per Share | -$3.99 |
| Basic Average Shares | 193,096,686 |
| Diluted Average Shares | 193,096,686 |
| Assets | $517.50M |
| Current Assets | $511.31M |
| Noncurrent Assets | $6.19M |
| Fixed Assets | $1.16M |
| Other Non-current Assets | $5.04M |
| Liabilities | $118.62M |
| Current Liabilities | $41.88M |
| Accounts Payable | $17.95M |
| Wages | $9.72M |
| Other Current Liabilities | $14.22M |
| Noncurrent Liabilities | $76.74M |
| Long-term Debt | $74.65M |
| Other Non-current Liabilities | $2.10M |
| Equity | $398.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $398.88M |
| Liabilities And Equity | $517.50M |
| Net Cash Flow From Operating Activities | -$210.29M |
| Net Cash Flow From Operating Activities, Continuing | -$210.29M |
| Net Cash Flow From Investing Activities | -$107.76M |
| Net Cash Flow From Investing Activities, Continuing | -$107.76M |
| Net Cash Flow From Financing Activities | $348.57M |
| Net Cash Flow From Financing Activities, Continuing | $348.57M |
| Net Cash Flow | $30.52M |
| Net Cash Flow, Continuing | $30.52M |
| Comprehensive Income/Loss | -$252.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$252.11M |
| Other Comprehensive Income/Loss | -$252.11M |